Global H1N1 2009 Influenza Vaccine Market

1
MarketsandMarkets Presents
Global H1N1 2009 Influenza Vaccine Market Worth
US 7,028 Million By 2011

http//www.marketsandmarkets.com/Market-Reports/i
nfluenza-vaccines-market-159.html
2
A new market research report, Global H1N1 2009
Influenza Vaccine, published by
MarketsandMarkets analyzes the market over the
period 2009-2012. The report studies the major
market drivers, restraints, and opportunities for
the market and also evaluates the major pandemic
trends with respect to different geographic
regions. Browse in-depth TOC on stem cell
market. http//www.marketsandmarkets.com/Market-
Reports/influenza-vaccines-market-159.html
Early buyers will receive 10 customization on
this report.
3
The global H1N1 2009 Influenza vaccine market is
estimated to be 7,028 billion by 2011, growing
at a CAGR of 222.4 from 2009 to 2011. Some of
the key players in this market are
GlaxoSmithKline, Novartis, CSL, MedImmune,
Sanofi-Pasteur, Solvay, Sinovac Biotech and
Hualun Biologicals. The global H1N1 2009
Influenza vaccine market is growing due to the
prevailing pandemic of H1N1 influenza and huge
demand from different countries for the vaccines
against it. The H1N1 Influenza vaccine market is
mainly driven by the increasing awareness of the
population, global spread of H1N1 influenza and
the initiatives taken by government other
public institutions for immunization of the
population against H1N1 influenza. The North
America region is the current lucrative market
for H1N1 influenza vaccines with other regions
also having high infection rate across the
population. Due to intensive ongoing research
and technology introduction, the market players
are compelled to understand the market dynamics,
innovations,  pricing, products, marketing and
regulatory framework of the market.
4
Scope And Format This report will enable
strategic understanding and opportunities in the
H1N1 2009 influenza vaccines market. The report
covers the following market segments. Vaccines
Markets Intramuscular Vaccines and Intranasal
vaccines. Geography Markets North America,
Europe, Asia-Pacific and ROW Each section of the
report offers market data with respect to
segments and geography. It also provides market
trends with respect to drivers, restraints and
opportunities. The report contains strategic
section with respect to competitive landscape and
market overview. The report will encompass around
15 company profiles.
5
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/in
fluenza-vaccines-market-159.html
6
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Bloghttp//twitter.com/market
smarkets
http//www.linkedin.com/company/marketsandmarkets